H
Héctor Herrera Bello
Publications - 5
Citations - 54
Héctor Herrera Bello is an academic researcher. The author has contributed to research in topics: Medicine & Therapeutic effect. The author has an hindex of 1, co-authored 4 publications receiving 15 citations.
Papers
More filters
Journal ArticleDOI
Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19.
Adrian Palacios Chavarria,Rafael Ricardo Valdez Vazquez,Jose Guillermo Dominguez Cherit,Héctor Herrera Bello,Humberto Castillejos Suastegui,Lidia Moreno-Castañeda,Gabriela Alanís Estrada,Fabián Hernández,Omar González-Marcos,Huitzilihuitl Saucedo-Orozco,Linaloe Manzano-Pech,Ricardo Márquez-Velasco,Verónica Guarner-Lans,Israel Pérez-Torres,María Elena Soto +14 more
TL;DR: Antioxidant therapy can be effective in this pandemia since it improves the survival scores including SOFA, Apache II, SAPS II, COVIDGRAM, GCS by lowering the LPO, IL-6, CRP, PCT and increasing systemic TAC and NO2 -.
Journal ArticleDOI
High-flow nasal cannula therapy for hypoxemic respiratory failure in patients with COVID-19.
Adrian Palacios Chavarria,Erika Salinas Lezama,Mauricio Gonzalez Navarro,Rafael Ricardo Valdez Vazquez,Héctor Herrera Bello,Julieta Lomelín Gascon,Linda Morales Juárez,Mónica Arboleya Avendaño,Luis Esteban Ramirez Gonzalez,Rodrigo Ville Benavides,Renate Victoria Álvarez Wyssmann,Brenda Sandoval Ortiz,Mariana Lizbeth Rodríguez de la Cerda,Lidia Moreno Castañeda,Luis Alberto Martinez-Juarez,Héctor Gallardo-Rincón,Roberto Tapia-Conyer +16 more
TL;DR: Treating patients with HFNC therapy at admission was effective and prevented the worsening of symptoms in some patients with COVID-19, and therapy was significantly associated with a lower intensive care unit admission rate and length of hospital stay.
Journal ArticleDOI
Anticoagulation Strategies in Non-Critically Ill Patients Hospitalized with COVID-19: A Randomized Clinical Trial
Gregg W. Stone,Michael E. Farkouh,Anuradha Lala,Elizabeth Tinuoye,Ovidiu Dressler,Pedro R. Moreno,Igor F. Palacios,Shaun G. Goodman,Rodrigo Barbosa Esper,Alexandre Abizaid,Deepak Varade,Alejandro Ricalde,Gerardo Payro,José M. Castellano,Ivan Hung,Girish N. Nadkarni,Gennaro Giustino,Lucas C. Godoy,J. M. Feinman,Anton Camaj,Solomon Bienstock,Remo H.M. Furtado,C.M. Granada,J. F. Pérez Bustamante,Carlos Peyra,Johanna Contreras,Ruth Owen,Deepak L. Bhatt,Stuart J. Pocock,Valentin Fuster,Jonathan Paul,Robert Pyo,Usman Baber,Jason Suh,Suraj Saggar,Sanjay S. Srivatsa,Megan Coylewright,Sandra Chapparo,Jairo Melo,Norma Keller,Alex Llanos,Edwin Chiu,Ibrahim Fahid,A. The,Ricardo Mauro Ghetti Cabral,Mauricio Antonio Pompilio,Leonardo Jorge Cordeiro de Paula,Jose Airton de Arruda,Roberto Kalil Filho,Bruno L. R. Faillace,Paulo Ricardo Avancini Caramori,Délcio Gonçalves da Silva Junior,Eduardo Kowalski Neto,Gibran Bhering Nascif,Bruno Mendonça Baccaro,Rafael Rebelo Cesar Cavalcanti,João Moraes Júnior,J F Betancur,Darío Echeverri,Fernán Mendoza Beltrán,Carlos Ramon Renowistki Zabarain,Eduardo Antonio Martinez Bula,A.M. Fernández,H. J. Meléndez Flórez,Wilder Castano Osorio,Absalon Antonio Clavijo Moldón,Antonio F. Moreno,Chun-Ka Wong,Madhu Varma,Aman Raj Khanna,Prasad Nikam,Ashpak Bangi,Jugal Bihari Gupta,Sudhir Bhandari,Shantanu Sengupta,Meenakshi Bhattacharya,Nihar Mehta,Deepesh G Aggarwal,Abhay Uppe,Andrea Calcagno,Patrizia Rovere Querini,Maria Lucia Narducci,Jessica Paola Guerrero,Ivan Elizalde,Héctor Herrera Bello,Otto Tavera Cabrera,Julieta Danira Morales Portano,Patricia Aubanel Riedel,G. Llamas Esperón,Jorge Armando Guareña Casillas,Jose R. Azpiri,J. Calvillo,Roberto Domínguez López,Nancy Quezada Barreto,Ricardo Restrepo Jaramillo,Mateusz Sokolski,Paula Villares Fernández,E. M. Moya Mateo,J. F. Varona Arche,P. Fanlo Mateo,Mercedes Villareal Garcia Lomas +100 more
TL;DR: In this paper , the safety and effectiveness of therapeutic-dose anticoagulation in noncritically ill patients with COVID-19 were evaluated in 76 centers in 10 countries, and the 30-day composite of all-cause mortality, requirement for intensive care unit-level of care, systemic thromboembolism, or ischemic stroke assessed in the combined therapeutic dose groups compared with the prophylactic-dose group.
Journal ArticleDOI
Impact of preemptive hospitalization on health outcomes at the temporary COVID-19 hospital in Mexico City: a prospective observational study.
Rafael Ricardo Valdez Vazquez,Héctor Gallardo-Rincón,Julieta Lomelin-Gascon,Rodrigo Ville Benavides,Linda Morales Juárez,Héctor Herrera Bello,Lidia Moreno Castañeda,Adrian Palacios Chavarria,Pablo Escalera Castillo,Luis Esteban Ramirez Gonzalez,Mónica Arboleya Avendaño,Santiago Treviño Berlanga,Reyna Albertina Rosas Loza,Renate Victoria Álvarez Wyssmann,Erika Salinas Lezama,Alonso Gutiérrez Romero,María Dolores Niembro Ortega,Liudmila Villegas Acosta,Ailyn Cendejas Schotman,Jennifer Bertin Montoya,Andrea Gonzalez Rodriguez,Laura María Badel Ramos,Luis Alberto Martinez-Juarez,Rodrigo Saucedo-Martínez,Alejandra Montoya,Roberto Tapia-Conyer +25 more
TL;DR: In response to the evolution of the coronavirus disease 2019 (COVID-19) pandemic, the admission protocol for the temporary COVID-2019 hospital in Mexico City has been updated as discussed by the authors.
Posted ContentDOI
Open Clinical Trial of the Use of Antioxidants and Pentoxifylline as Coadjuvant Measures to Standard Therapy to Improve Prognosis of Patients with Pneumonia and Septic Shock due to Covid-19
Adrian Palacios Chavarria,Rafael Ricardo Valdez Vazquez,Jose Guillermo Dominguez Cherit,Héctor Herrera Bello,Humberto Castillejos Suastegui,Lidia Moreno Castañeda,Gabriela Alanís Estrada,Fabián Valdez,Omar Marcos,Huitzilihuitl Orozco,Linaloe Pech,Ricardo Velasco,Verónica Guarner Lans,Israel Pérez Torres,María Elena Soto López +14 more
TL;DR: The antioxidant therapy can be effective in this pandemia since it improves all of the survival scores including SOFA, Apache II, SAPS II, COVIDGRAM, GCS by lowering the LPO, IL-6, CRP, PCT and increasing systemic TAC.